Disclosure 0001636282-26-000109-6

SEC FORM 4

$1,629,029.20

Spyre Therapeutics, Inc. (SYRE)

Sale of 18,232 shares at $89.35 per share.

Reporting Person Burrows Scott L · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001636282-26-000109 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Spyre Therapeutics, Inc. (SYRE)." Disclosed 2026-09-03. https://desqlong.com/cards/0001636282-26-000109-6 (retrieved 2026-09-26).